ambossIconambossIcon

Cardiac glycosides

Last updated: September 6, 2023

Summarytoggle arrow icon

Cardiac glycosides are drugs that inhibit the Na+/K+- ATPase found on the outer cell surface. Digoxin is the only drug of this class that is commonly used in clinical settings. The main indications for digoxin treatment are atrial fibrillation and heart failure in treatment-resistant cases. Because cardiac glycosides have a narrow therapeutic index, close monitoring of serum concentrations is necessary. Typical symptoms of cardiac glycoside poisoning are nausea, vomiting, blurry vision, and cardiac arrhythmias. Overdose can quickly become life-threatening and swift treatment is vital. The first-line treatment for cardiac glycoside poisoning is administration of digoxin-specific antibodies.

See also “Digoxin poisoning.”

Icon of a lock

Register or log in , in order to read the full article.

Overviewtoggle arrow icon

  • Drugs: digoxin, ouabain
  • Mechanism: inhibition of the cardiac and neuronal Na+/K+- ATPase
  • Onset of effect
    • Oral: 0.5–2 h
    • IV: 15–30 min
  • Half-life: 36–40 hours
  • Protein binding: 20–40%
  • Elimination: renal

References:[1][2][3][4]

Icon of a lock

Register or log in , in order to read the full article.

Pharmacodynamicstoggle arrow icon

Cardiac glycosides inhibit Na+/K+-ATPase, increasing cardiac contractility and decreasing AV conduction and heart rate!

Icon of a lock

Register or log in , in order to read the full article.

Cardiac glycoside poisoningtoggle arrow icon

Icon of a lock

Register or log in , in order to read the full article.

Indicationstoggle arrow icon

References:[3][8]

Icon of a lock

Register or log in , in order to read the full article.

Contraindicationstoggle arrow icon

References:[8]

We list the most important contraindications. The selection is not exhaustive.

Icon of a lock

Register or log in , in order to read the full article.

Interactionstoggle arrow icon

Icon of a lock

Register or log in , in order to read the full article.

Start your trial, and get 5 days of unlimited access to over 1,100 medical articles and 5,000 USMLE and NBME exam-style questions.
disclaimer Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer